• Organization TypeGovernment
  • HeadquartersPhilippines
  • Founded1981

Research Institute for Tropical Medicine (RITM)

The Research Institute for Tropical Medicine (RITM) was formally established in 1981 with the signing of Executive Order No. 674, authorizing the creation of a research facility under the Department of Health. This was funded by a grant-in-aid from the Government of Japan, administered through the Japan International Cooperation Agency (JICA). The RITM is tasked with planning and implementing research programs for infectious and/or tropical diseases.   In 1989, through another grant-in-aid from the Japanese Government, the RITM Center for Training in Tropical Infectious Diseases was established for the expansion and integration of the RITM core facilities.   In November 2000, the Biologicals Production Service (BPS) of the Department of Health was formally merged with the RITM. The history of BPS dates back in the 18th century under the Spanish Regime when King Charles IV sent a scientific mission to the Philippines. The objective of the mission was to look into the smallpox problem in the Philippines. The mission established the vaccine laboratory in the country with smallpox vaccine as the first product. The vaccine laboratory was later expanded to produce other vaccines as well as anti-sera.   The merger of RITM and BPS gave rise to a more comprehensive and logical approach in the control of infectious and/or tropical diseases through research and biologicals production.   Functions: Undertake research activities in the diagnosis, control and prevention of tropical diseases that are major causes of mortality and morbidity in the Philippines. Develop cost-effective strategies for the control of infectious/tropical diseases. Conduct clinical trials, according to accepted good clinical practice (GCP) guidelines, aimed at better understanding and control of tropical diseases. Conduct regular training courses for medical and paramedical personnel in the control of common tropical diseases in the country. Provide high quality tertiary care to both in-patients and out-patients suffering from tropical diseases included within the scope of the Institute's research activities. Participate in the technical cooperation programs with foreign government in research activities in the diagnosis, control and prevention of tropical diseases. Apply for, receive, and accept bequests, grants, and donation of funds, equipment, materials and services needed for the attainment of its objectives. Formulate plans of manufacturing of biological products for use of the DOH Manufacture of vaccines and biological products for use of the DOH Plan and execute research and development for the improvement of existing biological tests vaccines and anti-sera for human use according to accepted standards of current/certified good manufacturing practices (CGMP) Perform such other related activities as may be assigned by the Secretary of Health.  
See more

Company Offices

  • Philippines (headquarters)
  • Muntinlupa
  • 9002 Corporate Ave, DOH Compound
  • Metropolitan Manila 1781